Anika Therapeutics, Inc. (ANIK) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $25.79 -0.62%
EPS Growth %: -63.6%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: -63.6%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.51, $0.03 better than the analyst estimate of $0.48. Revenue for the quarter came in at $23.3 million versus the consensus estimate of $24.6 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Renasant Corp. (RNST) Tops Q1 EPS by 3c
- Trustmark Corp (TRMK) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
